Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001992324-25-000005

CFO & CBO sold 20,000 shares at $45.18 ($903,600)

  • CFO & CBO acquired 20,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Savitz Ryan CFO & CBO 2025-12-04 Option exercise 10b5-1 +20,000 $8.44 $168,800 20,000 D
Savitz Ryan CFO & CBO 2025-12-04 Sale 10b5-1 −20,000 $45.18 $903,600 0 D
Derivatives
Savitz Ryan CFO & CBO 2025-12-04 Option exercise · Stock Option (Right to Buy) 10b5-1 +20,000 84,766 D
Open-market sales · 20,000 sh · avg $45.18 · $903,600
Loading xslF345X05/ownership.xml…